Table 1.
Baseline characteristics of insulin resistant subjects 1
| Characteristic | Alternate Day Fasting | Calorie Restriction | Control | P-value 2 |
|---|---|---|---|---|
| Age – yr | 43 ± 3 | 42 ± 3 | 41 ± 3 | 0.96 |
| Sex – no. | ||||
| Female | 9 | 13 | 11 | 0.64 |
| Male | 2 | 4 | 4 | |
| Race or ethnic group – no. (%) | 0.76 | |||
| White | 5 | 7 | 6 | |
| Black | 4 | 9 | 9 | |
| Asian | 1 | 0 | 0 | |
| Hispanic | 1 | 1 | 0 | |
| Other | 0 | 0 | 0 | |
| Height – cm | 166 ± 2 | 167 ± 3 | 165 ± 2 | 0.71 |
| Weight – kg | 95 ± 5 | 101 ± 4 | 94 ± 3 | 0.38 |
| Body-mass index – kg/m2 | 34 ± 1 | 36 ± 1 | 35 ± 1 | 0.49 |
| Fasting glucose (mg/dl) | 99 ± 2 | 96 ± 2 | 95 ± 3 | 0.89 |
| Fasting insulin (μIU/mL) | 23 ± 4 | 22 ± 4 | 20 ± 4 | 0.52 |
| HOMA-IR | 5.6 ± 0.8 | 5.2 ± 1.0 | 4.7 ± 1.0 | 0.58 |
Values are expressed as means ± SEM. HOMA-IR: Homeostatic Model Assessment-Insulin Resistance.
1
Only subjects with insulin resistance who completed the full 12-month trial were included in the analysis (ADF n = 11, CR n = 17, control n = 15).
2
P-value: One-way ANOVA. No significant difference between groups for any variable at baseline.